Tormere Analytics
>/
OverviewMarket NewsStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

AH Bio Fund II, L.P.

10% Owner

SEC EDGAR ↗

10% Owner at Scribe Therapeutics, Inc., filing insider transactions on 2026-07-27.

Total Purchases
$5.0M
1 transaction
Total Sales
—
0 transactions
Companies Traded
1
1 total filings
Active Since
2026-07-27
Last: 2026-07-27

Companies

SCTX2026-07-27

Scribe Therapeutics, Inc.

↑ $5.0M (1)

Other Reporting Insiders at Scribe Therapeutics, Inc.

  • Behzad Aghazadeh
    Director
    Last filing 2026-07-28
  • Orbimed Advisors LLC
    Director
    Last filing 2026-07-27
  • Carl L. Gordon
    Director
    Last filing 2026-07-27
  • Svetlana Lucas
    Chief Business Officer
    Last filing 2026-07-23
  • David Parrot
    Chief Financial Officer
    Last filing 2026-07-23

Transaction History

DateTickerTypeSharesPriceValueOwned After
2026-07-27SCTXPurchase333.3K$15.00$5.0M2.39MSEC ↗